• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 11
  3. Author

Online ISSN: 2515-8260

Volume7, Issue11

CLINICAL SIGNIFICANCE OF URINARY MESSENGER RNA EXPRESSION OF ALPHA ACTIN, SYNAPTOPODIN, PODOCIN, AND PODOCALYXIN IN PROTEINURIC PATIENTS

    Malak Nabil Amin, Manar abd El Raouf Raafat, Emam Abd ElLatif Waked, Aya Abdelghany, Laila Nessim Kamel, Tarek Mahmoud Diab, Mohamed Abbas Shemis

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 5415-5423

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Podocyte biology is a science  promising a greater understanding of the mechanistic nature of proteinuria-related diseases. Injury to the podocytes and subsequent urinary excretion has a key role in glomerular disease pathogenesis and progression.
Aim: To obtain an insight into the clinical significance of urinary mRNA profile of podocytes in proteinuric patients, we evaluated urinary messenger RNA (mRNA) expression of four podocyte proteins: alpha actin, synaptopodin, podocin, and podocalyxin, in glomerular insults of different aetiologies: diabetes, HCV and  immune disorders and correlated them with proteinuria and renal function.
Methods: The study enrolled 80 proteinuric and non proteinuric  Egyptian patients and 20 apparently healthy controls.  Proteinuric patients (n=60) were divided into 3 groups according to etiology: HCV (n=20), nondiabetic (n=20) and diabetic (n=20) groups. In addition to a diabetic nonproteinuric group (n=20).  Quantification of mRNA of synaptopodin, podocin, alpha actin and podocalyxin, in urinary sediment was performed by Real-Time PCR.
 Results:  In the proteinuric HCV group the urinary mRNA levels of synaptopodin were significantly increased as compared to other diseased groups, Yet, no correlation was found between the urinary mRNA expression of the 4 podocyte proteins and HCV viral load.
In the proteinuric nondiabetic group: Age and serum creatinine and synaptopodin mRNA expression were significantly lower than group in HCV proteinuric group. Alpha actin mRNA was significantly higher as compared to proteinuric diabetic patients. Yet Podocin mRNA was significantly lower than the proteinuric diabetic patients. Podocalyxin mRNA inversely correlated to alpha actin mRNA.
In the proteinuric diabetic group: Proteinuria was significantly lower than both proteinuric HCV and proteinuric non- diabetic groups, and did not correlate to renal function or podocyte proteins.
  Urinary mRNA expression of alpha actin was significantly decreased as compared to control, proteinuric non diabetic and non- proteinuric diabetic groups. Also, the Podocin mRNA gene expression was significantly decreased when compared to proteinuric HCV and non-proteinuric diabetic.
In the non proteinuric diabetics, alpha actin mRNA correlated with creatinine clearance and Synaptopodin mRNA correlated with serum creatinine.
Podocalyxin mRNA showed no significant difference between any of the studied groups.
Conclusion: Our study found increased excretion of mRNA podocyte proteins in non proteinuric diabetes, and decrease with development of proteinuria which confirms the podocyte depletion hypothesis. HCV viral load has no effect on the excretion pattern. Urinary Synaptopodin mRN|A was increased in kidney disease regardless of urinary protein excretion. Podocalyxin mRNA showed no significant difference from controls.
Keywords:
  • PDF (285 K)
  • XML
(2021). CLINICAL SIGNIFICANCE OF URINARY MESSENGER RNA EXPRESSION OF ALPHA ACTIN, SYNAPTOPODIN, PODOCIN, AND PODOCALYXIN IN PROTEINURIC PATIENTS. European Journal of Molecular & Clinical Medicine, 7(11), 5415-5423.
Malak Nabil Amin, Manar abd El Raouf Raafat, Emam Abd ElLatif Waked, Aya Abdelghany, Laila Nessim Kamel, Tarek Mahmoud Diab, Mohamed Abbas Shemis. "CLINICAL SIGNIFICANCE OF URINARY MESSENGER RNA EXPRESSION OF ALPHA ACTIN, SYNAPTOPODIN, PODOCIN, AND PODOCALYXIN IN PROTEINURIC PATIENTS". European Journal of Molecular & Clinical Medicine, 7, 11, 2021, 5415-5423.
(2021). 'CLINICAL SIGNIFICANCE OF URINARY MESSENGER RNA EXPRESSION OF ALPHA ACTIN, SYNAPTOPODIN, PODOCIN, AND PODOCALYXIN IN PROTEINURIC PATIENTS', European Journal of Molecular & Clinical Medicine, 7(11), pp. 5415-5423.
CLINICAL SIGNIFICANCE OF URINARY MESSENGER RNA EXPRESSION OF ALPHA ACTIN, SYNAPTOPODIN, PODOCIN, AND PODOCALYXIN IN PROTEINURIC PATIENTS. European Journal of Molecular & Clinical Medicine, 2021; 7(11): 5415-5423.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 35
  • PDF Download: 38
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus